| Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools M Whiteman, S Le Trionnaire, M Chopra, B Fox, J Whatmore Clinical science 121 (11), 459-488, 2011 | 349 | 2011 |
| Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide M Whiteman, KM Gooding, JL Whatmore, CI Ball, D Mawson, K Skinner, ... Diabetologia 53, 1722-1726, 2010 | 265 | 2010 |
| Hydrogen sulfide and nitric oxide interactions in inflammation MLL Faro, B Fox, JL Whatmore, PG Winyard, M Whiteman Nitric oxide 41, 38-47, 2014 | 237 | 2014 |
| The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro D Gerő, R Torregrossa, A Perry, A Waters, S Le-Trionnaire, JL Whatmore, ... Pharmacological research 113, 186-198, 2016 | 157 | 2016 |
| The synthesis and functional evaluation of a mitochondria-targeted hydrogen sulfide donor,(10-oxo-10-(4-(3-thioxo-3 H-1, 2-dithiol-5-yl) phenoxy) decyl) triphenylphosphonium … S Le Trionnaire, A Perry, B Szczesny, C Szabo, PG Winyard, ... MedChemComm 5 (6), 728-736, 2014 | 140 | 2014 |
| ADP-ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase D in human neutrophils A Fensome, J Whatmore, C Morgan, D Jones, S Cockcroft Journal of Biological Chemistry 273 (21), 13157-13164, 1998 | 130 | 1998 |
| Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter JE Holley, J Newcombe, JL Whatmore, NJ Gutowski Neuroscience letters 470 (1), 65-70, 2010 | 110 | 2010 |
| ADP-ribosylation-factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionyl-leucyl-phenylalanine … CP Morgan, H Sengelov, J Whatmore, N Borregaard, S Cockcroft Biochemical Journal 325 (3), 581-585, 1997 | 104 | 1997 |
| In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells TA Tabish, MZI Pranjol, H Hayat, AAM Rahat, TM Abdullah, JL Whatmore, ... Nanotechnology 28 (50), 504001, 2017 | 91 | 2017 |
| Observation and characterisation of the glycocalyx of viable human endothelial cells using confocal laser scanning microscopy AL Barker, O Konopatskaya, CR Neal, JV Macpherson, JL Whatmore, ... Physical chemistry chemical physics 6 (5), 1006-1011, 2004 | 87 | 2004 |
| ADP-ribosylation factor 1-regulated phospholipase D activity is localized at the plasma membrane and intracellular organelles in HL60 cells J WHATMORE, CP MORGAN, E CUNNINGHAM, KS COLLISON, ... Biochemical Journal 320 (3), 785-794, 1996 | 87 | 1996 |
| The potential role of the proteases cathepsin D and cathepsin L in the progression and metastasis of epithelial ovarian cancer MZI Pranjol, N Gutowski, M Hannemann, J Whatmore Biomolecules 5 (4), 3260-3279, 2015 | 84 | 2015 |
| Investigation into the toxic effects of graphene nanopores on lung cancer cells and biological tissues TA Tabish, MZI Pranjol, F Jabeen, T Abdullah, A Latif, A Khalid, M Ali, ... Applied materials today 12, 389-401, 2018 | 73 | 2018 |
| Co-operation of phosphatidylinositol transfer protein with phosphoinositide 3-kinase γ in the formylmethionyl-leucylphenylalanine-dependent production of phosphatidylinositol 3 … G KULAR, M LOUBTCHENKOV, P SWIGART, J WHATMORE, A BALL, ... Biochemical Journal 325 (2), 299-301, 1997 | 69 | 1997 |
| Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents JL Whatmore, E Swann, P Barraja, JJ Newsome, M Bunderson, HD Beall, ... Angiogenesis 5, 45-51, 2002 | 62 | 2002 |
| Loss of the endothelial glycocalyx is associated with increased E-selectin mediated adhesion of lung tumour cells to the brain microvascular endothelium S Rai, Z Nejadhamzeeigilani, NJ Gutowski, JL Whatmore Journal of Experimental & Clinical Cancer Research 34, 1-12, 2015 | 61 | 2015 |
| Changes in inflammatory gene expression induced by hyperbaric oxygen treatment in human endothelial cells under chronic wound conditions AC Kendall, JL Whatmore, LW Harries, PG Winyard, GR Smerdon, ... Experimental cell research 318 (3), 207-216, 2012 | 58 | 2012 |
| Synthesis and evaluation of prodrugs for anti-angiogenic pyrrolylmethylidenyl oxindoles L Maskell, EA Blanche, MA Colucci, JL Whatmore, CJ Moody Bioorganic & medicinal chemistry letters 17 (6), 1575-1578, 2007 | 54 | 2007 |
| Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling BK Winiarski, KI Wolanska, S Rai, T Ahmed, N Acheson, NJ Gutowski, ... Translational oncology 6 (6), 703-IN23, 2013 | 51 | 2013 |
| Graphene oxide-based targeting of extracellular cathepsin D and cathepsin L as a novel anti-metastatic enzyme cancer therapy TA Tabish, MZI Pranjol, DW Horsell, AAM Rahat, JL Whatmore, ... Cancers 11 (3), 319, 2019 | 49 | 2019 |
